Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.
about
Myeloid cell signatures in tumor microenvironment predicts therapeutic response in cancerT cell exclusion, immune privilege, and the tumor microenvironmentFunctional significance of mononuclear phagocyte populations generated through adult hematopoiesisImproved mouse models to assess tumour immunity and irAEs after combination cancer immunotherapiesRegulatory T Cells Contribute to the Inhibition of Radiation-Induced Acute Lung Inflammation via Bee Venom Phospholipase A₂ in Mice.Rapid dissemination of RET-transgene-driven melanoma in the presence of non-obese diabetic alleles: Critical roles of Dectin-1 and Nitric-oxide synthase type 2.Propranolol induces a favourable shift of anti-tumor immunity in a murine spontaneous model of melanoma.Targeting regulatory T cells in tumors.Sepsis-induced expansion of granulocytic myeloid-derived suppressor cells promotes tumour growth through Toll-like receptor 4.One microenvironment does not fit all: heterogeneity beyond cancer cells.Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site.Monocyte-Derived Dendritic Cells Are Essential for CD8(+) T Cell Activation and Antitumor Responses After Local Immunotherapy.Crucial role of inflammatory monocytes in antitumor immunityMacrophages Induce Long-Term Trapping of γδ T Cells with Innate-like Properties within Secondary Lymphoid Organs in the Steady State.IL4-induced gene 1 promotes tumor growth by shaping the immune microenvironment in melanoma.Macrophages, Neutrophils, and Cancer: A Double Edged Sword
P2860
Q26752838-D9156037-7BFB-439F-A9B9-A4813A87189EQ28259872-9A526C8E-640F-40D6-8CA5-73097C9CAEF7Q30366001-E4765FC5-34EB-4382-8A04-66FC012631B9Q34511672-2A366586-2267-47D1-80D9-970AC11A2D87Q36946923-164B1B8E-70BB-4D61-ADB4-7AB0808EBB43Q37012718-ACCAFA93-FBA5-49DF-80F8-C131D7A3FDB9Q37718449-9AC2D059-93BB-475E-A066-2C0006DE4E1BQ38703565-424AFCEF-F3A4-40E4-B254-25C4158152B7Q38771038-97292BB1-B5F1-4D69-81FE-4CC71A02E842Q39011826-E3297F5A-13DF-4F07-B2C4-E6BDB917649FQ40576387-049C1828-A273-4E7D-8B9B-66A95BCB9187Q42740331-371AC50B-4FCC-4690-BA95-C7A95E5C9F8AQ42796239-8155DD2B-094F-47F3-A4E6-86A010E361C1Q47988859-ACB1953A-8703-4D5F-9B6B-88BBE6B68D4DQ53881415-77011D58-AE38-40DE-866B-FB76613C0BC0Q56942176-B14D2F32-77A2-4A0C-9FF2-FFFAF84FF729
P2860
Inflammatory monocytes are potent antitumor effectors controlled by regulatory CD4+ T cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inflammatory monocytes are pot ...... ed by regulatory CD4+ T cells.
@en
Inflammatory monocytes are pot ...... ed by regulatory CD4+ T cells.
@nl
type
label
Inflammatory monocytes are pot ...... ed by regulatory CD4+ T cells.
@en
Inflammatory monocytes are pot ...... ed by regulatory CD4+ T cells.
@nl
prefLabel
Inflammatory monocytes are pot ...... ed by regulatory CD4+ T cells.
@en
Inflammatory monocytes are pot ...... ed by regulatory CD4+ T cells.
@nl
P2093
P2860
P50
P356
P1476
Inflammatory monocytes are pot ...... led by regulatory CD4+ T cells
@en
P2093
Alexandra Audemard
Armelle Le Campion
Arnaud Pommier
Aurélie Durand
Cédric Auffray
Laetitia Douguet
Marie-Françoise Avril
Masashi Kato
Renée Lengagne
P2860
P304
13085-13090
P356
10.1073/PNAS.1300314110
P407
P577
2013-07-22T00:00:00Z